Search results for "Guidelines"

showing 10 items of 617 documents

Executive summary of the joint position paper on renal denervation of the Cardiovascular and Interventional Radiological Society of Europe and the Eu…

2016

Renal denervation (RDN) was reported as a novel exciting treatment for resistant hypertension in 2009. An initial randomized trial supported its efficacy and the technique gained rapid acceptance across the globe. However, a subsequent large blinded, sham arm randomized trial conducted in the USA (to gain Food and Drug Administration approval) failed to achieve its primary efficacy end point in reducing office blood pressure at 6 months. Published in 2014 this trial received both widespread praise and criticism. RDN has effectively stopped out with clinical trials pending further evidence. This joint consensus document representing the European Society of Hypertension and the Cardiovascular…

medicine.medical_specialtyPathologyConsensusPhysiologyCoronary VasospasmBlood PressureConsensu030204 cardiovascular system & hematologyKidneylaw.invention03 medical and health sciences0302 clinical medicineRandomized controlled triallawmedicineInternal MedicineHumans030212 general & internal medicineConsensus documentDenervationExecutive summarymedicine.diagnostic_testbusiness.industryInterventional radiologymedicine.diseaseDenervationResistant hypertensionBlood pressureRadiological weaponCoronary vasospasmHypertensionPractice Guidelines as TopicPhysical therapyPosition paperRenal denervationbusinessCardiology and Cardiovascular MedicineHumanJournal of hypertension
researchProduct

The 2016 European Thyroid Association/European Group on Graves' Orbitopathy Guidelines for the Management of Graves' Orbitopathy

2015

Graves' orbitopathy (GO) is the main extrathyroidal manifestation of Graves' disease, though severe forms are rare. Management of GO is often suboptimal, largely because available treatments do not target pathogenic mech anisms of the disease. Treatment should rely on a thorough assessment of the activity and severity of GO and its impact on the patient's quality of life. Local measures (artificial tears, ointments and dark glasses) and control of risk factors for progression (smoking and thyroid dysfunction) are recommended for all patients. In mild GO, a watchful strategy is usually sufficient, but a 6-month course of selenium supplementation is effective in improving mild manifestations …

medicine.medical_specialtyPediatricsCyclosporine; Eyelid surgery; Glucocorticoids; Graves' orbitopathy; Orbital decompression; Orbital radiotherapy; Rituximab; Selenium; Squint surgeryEndocrinology Diabetes and Metabolismmedicine.medical_treatmentMedizin030209 endocrinology & metabolismDiseaseGuidelines03 medical and health sciencesGraves' orbitopathySeleniumEndocrinology0302 clinical medicineQuality of lifemedicineEyelid surgeryOrbital radiotherapyGlucocorticoidsbusiness.industryCumulative doseThyroideye diseasesSurgeryDiabetes and MetabolismOrbital decompressionArtificial tearsmedicine.anatomical_structureMethylprednisolone030221 ophthalmology & optometryCyclosporineRituximabSquint surgerybusinessRituximabWatchful waitingCyclosporine; Eyelid surgery; Glucocorticoids; Graves' orbitopathy; Orbital decompression; Orbital radiotherapy; Rituximab; Selenium; Squint surgery; Endocrinology Diabetes and Metabolismmedicine.drug
researchProduct

Evaluation of the quality of publications on randomized clinical trials using the Consolidated Standards of Reporting Trials (CONSORT) statement guid…

2011

The main reason for conducting a clinical trial (CT) is to test the effect of a drug or medical procedure to improve treatment of a disease. CTs contribute most when they are rigorously conducted and the results are published adequately. The aim of this study is to assess, using the CONSORT statement guidelines, the quality of reporting of completed CTs conducted at a tertiary hospital to determine which sections of the articles should be improved. CTs published between 2002 and 2008 were identified by searching the MEDLINE and Cochrane Library. Forty of 127 completed CTs were published. There was a marked increase in the number of articles and the quality of the journals that published the…

medicine.medical_specialtyPediatricsMedical procedureAlternative medicineMEDLINEGuidelines as TopicCochrane Librarylaw.inventionHospitals UniversityRandomized controlled triallawmedicineHumansPharmacology (medical)Randomized Controlled Trials as TopicPharmacologybusiness.industryConsolidated Standards of Reporting Trialsnervous system diseasesTest (assessment)Clinical trialSpainFamily medicineJournal Impact FactorPeriodicals as TopicbusinessJournal of clinical pharmacology
researchProduct

A survey on current practice in the neurosurgical management of preterm infants with posthemorrhagic hydrocephalus in Germany.

2012

Background and Study Aims  Different approaches to the management of preterm infants with posthemorrhagic hydrocephalus (PHH) are described in the literature. Likewise, neurosurgical and pediatric surgical departments in German hospitals use different methods to treat these patients. The aim of this study was therefore to assess the current situation regarding the management of PHH, which is a first and essential step toward the development of standards of practice. Patients and Methods  In the second half of 2009, we sent standardized questionnaires to 139 neurosurgical departments (number of returned questionnaires: 98) and 73 pediatric surgical departments (returned questionnaires: 62) t…

medicine.medical_specialtyPediatricsNeurosurgeryPediatricsVentriculoperitoneal ShuntNeurosurgical ProceduresVentriculoperitoneal shuntsPosthemorrhagic hydrocephalusGermanySurveys and QuestionnairesPediatric surgeryMedicineInitial treatmentHumansPractice Patterns Physicians'Csf shuntbusiness.industryData CollectionInfant Newbornmedicine.diseasehumanitiesIntraventricular hemorrhageCurrent practicePractice Guidelines as TopicSurgeryNeurology (clinical)NeurosurgerybusinessIntracranial HemorrhagesInfant PrematureHydrocephalusJournal of neurological surgery. Part A, Central European neurosurgery
researchProduct

Agreement within Europe about antihypertensive treatment and education – results from the European Society of Hypertension questionnaire

2010

medicine.medical_specialtyPediatricsPhysiologybusiness.industrymedia_common.quotation_subjectMEDLINEAgreementEuropeFamily medicineHypertensionPractice Guidelines as TopicInternal MedicinemedicineHumansMulticenter Studies as TopicCardiology and Cardiovascular MedicinebusinessAntihypertensive Agentsmedia_commonJournal of Hypertension
researchProduct

How is stroke care organised in Europe?

2016

Summary Introduction There is a wide difference in stroke care in European Countries, conditioning the performance in stroke management. Objective The authors review current national and regional stroke organisational models and their adherence to current European Stroke Organisation (ESO) guidelines across the Europe and on-going European Stroke Projects. Stroke Care Models investigated in: Austria, Switzerland, Bavaria (Germany), London and Greater Manchester in the UK, Catalonia (Spain), Lombardy Region in Italy, Poland and Northern Portugal. Discussion There is a lack of uniform stroke care in European Countries as defined by current ESO guidelines. For this reason, ESO has established …

medicine.medical_specialtyPediatricsbusiness.industryGeneral MedicineModels TheoreticalStroke caremedicine.diseaseEuropeStroke03 medical and health sciences0302 clinical medicineStroke preventionFamily medicinePractice Guidelines as TopicEpidemiologymedicineHumansCerebral ischaemiacardiovascular diseases030212 general & internal medicinebusinessStroke030217 neurology & neurosurgeryLa Presse Médicale
researchProduct

Natalizumab therapy of multiple sclerosis: recommendations of the Multiple Sclerosis Study Group-Italian Neurological Society

2011

Three years after the introduction of natalizumab (NA) therapy for the second line treatment of relapsing-remitting multiple sclerosis (MS), Italian MS centers critically reviewed the scientific literature and their own clinical experience. Natalizumab was shown to be highly efficacious in the treatment of MS. However, the risk of progressive multifocal leukoencephalopathy was confirmed and defined better. This article summarizes the MS-SIN Study Group recommendations on the use of NA in MS, with particular reference to the appropriate selection and monitoring of patients as well as to the management of adverse events.

medicine.medical_specialtyPediatricspml; iris; multiple sclerosis; natalizumabMultiple SclerosisNeurologypmlMEDLINEProgressive MultifocalDermatologyRelapsing-RemittingAntibodies Monoclonal HumanizedAntibodiesLeukoencephalopathyMultiple Sclerosis Relapsing-RemittingNatalizumabLeukoencephalopathyMonoclonalmedicineHumansAdverse effectAntibodies; Monoclonal; Humanized Antibodies; therapeutic use Humans Leukoencephalopathy; Progressive Multifocal; chemically induced Multiple Sclerosis; Relapsing-Remitting; drug therapyHumanizedMultiple sclerosis Natalizumab PML IRISirisbusiness.industryNatalizumabProgressive multifocal leukoencephalopathyMultiple sclerosisLeukoencephalopathy Progressive MultifocalAntibodies MonoclonalGeneral Medicinemedicine.diseasedrug therapyPsychiatry and Mental healththerapeutic usechemically inducednatalizumab multiple sclerosis treatment guidelinesPhysical therapySettore MED/26 - NeurologiaNeurology (clinical)Neurosurgerybusinessmedicine.drug
researchProduct

Low Back Pain: Guidelines for the Clinical Classification of Predominant Neuropathic, Nociceptive, or Central Sensitization Pain

2015

Background: Low back pain (LBP) is a heterogeneous disorder including patients with dominant nociceptive (e.g., myofascial low back pain), neuropathic (e.g., lumbar radiculopathy), and central sensitization pain. In order to select an effective and preferably also efficient treatment in daily clinical practice, LBP patients should be classified clinically as either predominantly nociceptive, neuropathic, or central sensitization pain. Objective: To explain how clinicians can differentiate between nociceptive, neuropathic, and central sensitization pain in patients with LBP. Study Design: Narrative review and expert opinion. Setting: Universities, university hospitals and private practices. …

medicine.medical_specialtyPopulationMEDLINENociceptive PainDiagnosis DifferentialPhysical medicine and rehabilitationSurveys and QuestionnairesChronic fatigue syndromemedicineHumanseducationPain Measurementeducation.field_of_studybusiness.industryChronic painmedicine.diseaseLow back painAnesthesiology and Pain MedicineNociceptionPractice Guidelines as TopicNeuralgiaPhysical therapyNeuralgiaDifferential diagnosismedicine.symptombusinessLow Back PainPain Physician
researchProduct

ESMO Consensus Conferences: another source of ESMO Clinical Practice Guidelines.

2012

23 SUPPL. 7 vii7 vii10

medicine.medical_specialtyPractice guidelinePractice guidelines as topicConsensus Development Conferences as Topic2720 Hematology610 Medicine & healthCancer researchOrganizational objectivesClinical practiceMedical decision makingHealth care organizationMedicalNeoplasmsMedicineHumansOrganizational ObjectivesMedical physicsSocieties MedicalPriority journalbusiness.industryMedical literatureOrganizational efficiencyProfessional standardConsensus development conferences as topicHematologyConsensus developmentOrganizational developmentClinical PracticeEuropeEditorialOncology10032 Clinic for Oncology and HematologyPractice Guidelines as Topic2730 OncologybusinessInternational cooperationSocietiesHumanAnnals of oncology : official journal of the European Society for Medical Oncology
researchProduct

Modern Strategies in the Prevention of Implant-Associated Infections

2005

The application of medical devices either for temporary or permanent use has become an indispensible part of almost all fields of medicine. However, foreign bodies are associated with a substantial risk of bacterial and fungal infections. Implant-associated infections significantly contribute to the still increasing problem of nosocomial infections. To reduce the incidence of such infections, specific guidelines providing evidence-based recommendations and comprising both technological and nontechnological strategies for prevention have been established. Strict adherence to hygienic rules during insertion or implantation of the device are aspects of particular importance. Besides such basi…

medicine.medical_specialtyProsthesis-Related InfectionsFuture studiesmedicine.drug_class0206 medical engineeringAntibioticsBiomedical EngineeringMedicine (miscellaneous)New materialsBioengineering02 engineering and technologyBiologyProsthesis DesignBacterial AdhesionBiomaterialsCoated Materials BiocompatiblemedicineHumansConnective Tissue ProteinsIntensive care medicineForeign BodiesInfection ControlGeneral Medicine021001 nanoscience & nanotechnologyAntimicrobial020601 biomedical engineeringAnti-Bacterial AgentsSurgeryPractice Guidelines as TopicEquipment Contamination0210 nano-technologyThe International Journal of Artificial Organs
researchProduct